Mike Zurawski

Mike has spent several years as a VC & PE investor for a multi-billion-pound Single Family Office based in London, overseeing their direct healthcare investments in therapeutics, medtech, digital health & AI, at all stages of the VC investment lifecycle (seed – pre-IPO rounds).

Mike is Co-Founder and CEO of MICA Biosystems, a pioneering nanotech synthetic biology company now entering its clinical therapeutic phase in the UK. He is on the 2025 Forbes 30 Under 30 List (Science & Healthcare) in recognition of his achievements within healthcare. He has been Chairman of the Board at Neuro-Bio, an Alzheimer’s disease diagnostic and therapeutic company led by Baroness Susan Greenfield, where he now chairs the Commercial Advisory Board. He has also led several M&A and restructure projects in tech & AI, served as Chairman of an AI fintech company and continues to advise Family Offices and Private Equity firms.

Mike has also served in the British Army Reserve, as a Team Medic in the Royal Yeomanry, since 2017, and is on the roster of Experts for the European Commission in the verticals of Healthcare, Biotechnology & Therapeutics. His involvement in All-Party Parliamentary Groups on Dementia within His Majesty’s Government underscores his dedication to shaping healthcare policy.